Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (June 10, 2008). doi:10.1152/physiolgenomics.90254.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/3/239    most recent
90254.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Latronico, M. V. G.
Right arrow Articles by Condorelli, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latronico, M. V. G.
Right arrow Articles by Condorelli, G.
Submitted on May 20, 2008
Revised on June 4, 2008
Accepted on June 5, 2008

MicroRNA and cardiac pathologies

Michael V. G. Latronico1, Daniele Catalucci, and Gianluigi Condorelli2*

1 IRCCS MultiMedica
2 University of California San Diego

* To whom correspondence should be addressed. E-mail: gcondorelli{at}ucsd.edu.

MicroRNA has been shown to be essential for correct cardiovascular development and physiology in a number of recent reports. Studies have also started to characterize the link between specific microRNAs and aspects of pathogenesis - such as chamber morphogenesis, conduction, and contraction - and between microRNA expression signatures and pathological cardiac phenotypes - such as hypertrophy, ischemic cardiomyopathy, dilated cardiomyopathy, and aortic stenosis. Congenital anomalies of the heart may also be associated with the dysregulation of specific microRNAs. Here we report on the latest findings.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.